Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Oct-23 10:08 AM View:  | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Grant | 170,000 | -- | -- | 29% 596.24K to 766.24K | |
| 11-Oct-23 10:08 AM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 10-Oct-23 | Disposition (change in control) | 766,241 | -- | -- | (100%) 766.24K to 0 | |
| 14-Sep-23 4:14 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 13-Sep-23 | Sale | 12,401 | $1.33 | $16,440.00 | (2%) 608.64K to 596.24K | |
| 14-Sep-23 4:14 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 12-Sep-23 | Grant | 45,000 | -- | -- | 8% 563.64K to 608.64K | |
| 09-Feb-23 5:11 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 08-Feb-23 | Payment of Exercise | 9,973 | $0.60 | $5,948.89 | (2%) 573.62K to 563.64K | |
| 09-Feb-23 5:11 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 07-Feb-23 | Grant | 36,044 | -- | -- | 7% 537.57K to 573.62K | |
| 02-Feb-23 8:06 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 01-Feb-23 | Payment of Exercise | 9,321 | $0.60 | $5,547.86 | (2%) 546.89K to 537.57K | |
| 02-Feb-23 8:06 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 31-Jan-23 | Grant | 33,688 | -- | -- | 7% 513.2K to 546.89K | |
| 25-Jan-23 5:29 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 24-Jan-23 | Grant | 170,000 | -- | -- | 50% 343.2K to 513.2K | |
| 25-Jan-23 5:29 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 23-Jan-23 | Sale | 24,661 | $0.60 | $14,742.30 | (7%) 367.87K to 343.2K | |
| 20-Jul-22 4:08 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 19-Jul-22 | Sale | 8,281 | $1.10 | $9,109.10 | (2%) 376.15K to 367.87K | |
| 20-Jul-22 4:08 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 18-Jul-22 | Grant | 30,000 | -- | -- | 9% 346.15K to 376.15K | |
| 28-Jan-22 4:14 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 26-Jan-22 | Grant | 85,000 | -- | -- | 33% 261.15K to 346.15K | |
| 25-Jan-21 4:19 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 21-Jan-21 | Grant | 75,000 | -- | -- | 40% 186.15K to 261.15K | |
| 28-Jan-19 4:20 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 24-Jan-19 | Grant | 3,600 | -- | -- | 2% 182.55K to 186.15K | |
| 07-Aug-18 4:29 PM View: | Zynerba Pharmaceuticals, Inc. (ZYNE) | 06-Aug-18 | Market Purchase | 3,800 | $5.79 | $22,013.40 | 2% 178.75K to 182.55K | (39%) |
| 25-Feb-14 10:40 AM View: | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition | 179,182 | $6.80 | $1,218,440.00 | (50%) 355.88K to 176.7K | |
| 25-Feb-14 10:40 AM View: | Nupathe Inc. (PATH) | 21-Feb-14 | Disposition (change in control) | 176,699 | $6.80 | $1,201,550.00 | (100%) 176.7K to 0 | |
| 12-Jun-13 2:12 PM View: | Nupathe Inc. (PATH) | 10-Jun-13 | Grant | 30,000 | -- | -- | 9% 330.57K to 360.57K | |
| 22-Jan-13 10:06 AM View: | Nupathe Inc. (PATH) | 17-Jan-13 | Grant | 125,000 | -- | -- | 61% 205.57K to 330.57K | |
| 09-Jan-13 6:32 PM View: | Nupathe Inc. (PATH) | 07-Jan-13 | Grant | 37,136 | -- | -- | 22% 168.44K to 205.57K | |
| 27-Jul-04 7:49 PM View: | Auxilium Pharmaceuticals Inc. (AUXL) | 23-Jul-04 | Grant | 5,920 | -- | -- | 19% 32.0K to 37.92K |